SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-205605
Filing Date
2021-07-01
Accepted
2021-07-01 08:10:00
Documents
3
Period of Report
2021-07-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d235024d8k.htm 8-K 18126
2 EX-99.1 d235024dex991.htm EX-99.1 11521
3 GRAPHIC g235024g25g25.jpg GRAPHIC 3527
  Complete submission text file 0001193125-21-205605.txt   35761
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38293 | Film No.: 211064110
SIC: 2834 Pharmaceutical Preparations